Skip to main content
OpenTrials

Clinical trial condition

Male Urogenital Diseases

Explore clinical trials studying Male Urogenital Diseases. Study availability and eligibility vary by location and protocol.

20,884 public trials 3,487 recruiting studies
Refine in advanced search Browse all conditions

Male Urogenital Diseases trial results

Recruiting

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

NCT06394869

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • Urology Centers of Alabama Homewood, Alabama, United States
  • Urology Associates of Mobile Mobile, Alabama, United States
  • Urology Associates of Central California Fresno, California, United States
  • Urology Group of Southern California Los Angeles, California, United States
View all 20 locations
View Trial Details
Recruiting

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

NCT07140900

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
View all 16 locations
View Trial Details
Recruiting

A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies

NCT06839105

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +40 more
Locations
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
  • The First Affiliated Hospital of Henan University of Science & Technology Luoyang, Henan, China
View all 13 locations
View Trial Details
Recruiting

Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.

NCT07483658

Conditions
Biochemical Recurrence of Malignant Neoplasm of Prostate, Digestive System Diseases, Female Urogenital Diseases, +22 more
Locations
  • Gatineau Hospital Gatineau, Quebec, Canada
  • Hôpital Général Juif Montreal, Quebec, Canada
  • McGill University Health Centre Montreal, Quebec, Canada
  • CHU de Québec-Université Laval Québec, Quebec, Canada
View Trial Details

Related conditions